May 3, 2017 07:01 AM EDT
Pharma

Ex­pan­sive So­sei lays out a $534M ac­qui­si­tion plan for the am­bi­tious saR­NA biotech Mi­NA

John Carroll

Editor & Founder

Af­ter swoop­ing in to buy Hep­tares a cou­ple of years ago in a $400 mil­lion deal, So­sei has put a new ac­qui­si­tion play in mo­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times